Alan C. Braverman, MD, FACC, Alumni Endowed Professor of Cardiovascular Diseases, section head of General Cardiology, and director of the Marfan Syndrome and Aortopathy Center at WashU Medicine, was honored during the Cleveland Clinic Comprehensive, Lifelong, Expeditious (CLE) Care of Aortic Disease Symposium, held Sept. 18-19, 2026. The symposium brought together internationally recognized experts to discuss advances in the diagnosis and treatment of aortic aneurysms, aortic dissections, aortic valve disease, genetics, imaging and lifelong aortic care.
A highlight of the meeting was a special luncheon, “Living Legends: From Lifesaving to Lifelong Care,” celebrating Braverman’s decades of contributions to cardiovascular medicine and his leadership in caring for patients with Marfan syndrome, heritable thoracic aortic disease and other aortopathies. Braverman was recognized for his longstanding commitment to improving outcomes for patients with inherited and complex aortic conditions.
Braverman is internationally recognized for his expertise in genetic and heritable aortic disorders and has helped develop one of the nation’s largest multidisciplinary programs dedicated to the care of patients and families affected by inherited aortic disease. Through his clinical leadership, research and patient advocacy, he has advanced understanding of conditions including Marfan syndrome, Loeys-Dietz syndrome, bicuspid aortic valve aortopathy and thoracic aortic aneurysm and dissection.
The honor reflects Braverman’s enduring impact on the field of aortic medicine and the national leadership of WashU Medicine Cardiology in advancing care for patients with complex cardiovascular disease.